- Published on 24 June 2014
MED-EL announced the official launch of the SYNCHRONY system – a new cochlear implant system. It includes the SYNCHRONY (PIN) implant* offering the greatest MRI safety possibilities currently on the cochlear implant market (high-resolution MRI scans up to 3.0 Tesla) and the SONNET audio processor specifically designed to mimic the processing of sound more naturally. These features make the SYNCHRONY system the new pioneering solution for all cochlear implant candidates. The new SYNCHRONY cochlear implant system will be available in all countries that recognize the CE mark.
Additionally the new system is based on MED-EL’s Triformance concept. The unique Triformance concept combines Complete Cochlear Coverage, Structure Preservation and the FineHearing sound coding technology to deliver the best possible hearing to cochlear implant recipients.
Dr. Ingeborg Hochmair, CEO of MED-EL, is pleased to officially announce the launch of the new cochlear implant system: “Never before has the market seen a cochlear implant that doesn’t require surgical removal of the magnet for a high-resolution, 3.0 Tesla MRI scan”. “Combined with a new audio processor that offers advanced technologies available only from MED-EL, the SYNCHRONY Cochlear Implant can give our recipients the best speech and music perception possible today. We are proud to bring such an innovative CI system to the market.”
* The SYNCHRONY (PIN) implant is pending regulatory approval
Prolonged use of sound amplification apps such as Google's Sound Amplifier may cause hearing problems instead of easing them, warns the National Association of Audiologists of Spain (ANA).
There will be a massive roar in Japanese stadiums hosting the Rugby World Cup, which starts on Friday September 20, but it will barely compete with the street noise in the country with the world's worst acoustic pollution problem.
In a move that Apple claims will allow customers to contribute to medical discoveries, the phone and computer giant is to conduct three large-scale health studies, one of them into the impact of everyday sound exposure on hearing.
Oticon has appointed a new Vice President of Sales, Roger Peterson, who will work from the Danish multinational's US head office in Somerset, New Jersey, reporting to Oticon President Gary Rosenblum.
A seesaw in hearing aid sales is the only clear market indicator so far of any effect of the Brexit process in the UK and Ireland, but there is a simple explanation behind the latest figures.
Potential therapeutic benefits for a range of conditions including tinnitus have been glimpsed thanks to newly published research involving vagus nerve stimulation (VNS) in rats.
Oticon completes its hearing aid portfolio with the launch of the Oticon Xceed and Oticon Xceed Play power hearing aids for profound hearing loss. Hearing care professionals now have access to the most updated hearing aid portfolio on the market with a complete range of hearing aids, all featuring the Velox S platform.[ ... ]
Phonak, the world’s leading hearing aid provider, has launched Marvel 2.0, "the next generation of Marvel technology developed to give hearing aid wearers even more hearing performance, more connectivity and more choice".[ ... ]